Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder

Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder

Study objectives: Lemborexant (LEM) is a dual orexin receptor antagonist approved for treating adults with insomnia. We analyzed the efficacy (subjective sleep outcomes) and safety of LEM over 12 months in the subgroup of Asian subjects from Study E2006-G000-303 (Study 303). Methods: Study 303 was a...

Full description

Bibliographic Details
Main Authors: Amitabh Dash, Kate Pinner, Yuichi Inoue, Kenichi Hayashida, Sung Chul Lim, Chang-Ho Yun, Tsuo-Hung Lan, Chieh-Liang Huang, Jane Yardley, Naoki Kubota, Margaret Moline
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Sleep Medicine: X
Subjects:
Asian continental ancestry group
Dual orexin receptor antagonist
Treatment efficacy
Hypnotics and sedatives
Insomnia disorder
Lemborexant
Online Access:http://www.sciencedirect.com/science/article/pii/S2590142722000039

Internet

http://www.sciencedirect.com/science/article/pii/S2590142722000039

Similar Items